anti-FcgRIIb antibody/anti-PD-1 antibody (BioInvent)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-FcgRIIb antibody/anti-PD-1 antibody (BioInvent)
Drug Alias Namedual CD32b checkpoint inhibitor/PD-1 checkpoint inhibitor (BioInvent)dual FcgRIIb checkpoint inhibitor/PD-1 checkpoint inhibitor (BioInvent)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor II-b antagonistsProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1Low affinity immunoglobulin gamma Fc region receptor II-b
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioinvent International Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioinvent International Ab
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A